Metabolic-Fit / 100
PlexusDx review
Elena Voss is a mother writing for mothers, not a treating clinician, and holds no medical license. Prices and terms come from the company's own published pages. This is background reading, not medical advice.
Semaglutide: $189/mo monthly ($149/mo on a 6-month plan); tirzepatide: $289/mo monthly ($249/mo on a 6-month plan). The lower $149 and $249 figures require six-month plans; the optional $99 genetic test is additional.
- Confirm HSA / FSA coverage
- Public information reviewed
- Confirm your total cost
PlexusDx at a glance
- Semaglutide
- $189/mo monthly ($149/mo on a 6-month plan)
- Tirzepatide
- $289/mo monthly ($249/mo on a 6-month plan)
- Coverage
- All 50 states
- Brand-name
- Compounded only
How we scored PlexusDx
Every factor comes from PlexusDx's own published pricing, disclosures and oversight, and the six combine into the 48/100 Metabolic-Fit Score on our weighted six-factor framework. Commissions don't change a provider's score.
No postpartum or breastfeeding framing — a generic weight program.
Thin on the hormonal picture that drives many mothers' weight.
Oversight and lab support fall short of the best on our list — the review below says exactly where.
Cost is unpredictable or sits at the premium end.
Support is thin once the prescription ships.
Exit terms are the weak point: lock-in, notice periods, or a cancellation you have to chase.
How we checked this review
Semaglutide: $189/mo monthly ($149/mo on a 6-month plan); tirzepatide: $289/mo monthly ($249/mo on a 6-month plan). The lower $149 and $249 figures require six-month plans; the optional $99 genetic test is additional.
Before you sign up
What PlexusDx's public site and signup page show before you hand over any details.
Worth knowing
- The homepage lists a full menu of GLP-1 tiers with real starting prices directly — microdose, standard semaglutide, and tirzepatide — no intake required to see the numbers
- The site states a provider picks the specific compound and dose that fits the patient's clinical profile from a family of options
- Also offers separate longevity/peptide programs starting at $99/mo, on the same platform
- One of the more granular pricing menus — three distinct GLP-1 tiers (microdose, semaglutide, tirzepatide) each with a real starting price, all visible before intake
- Also names an exclusive 'GLP-Squared' product — a single weekly injection combining both semaglutide and tirzepatide, also 'Starts at $249/mo' — a real, distinct offering our schema doesn't have a field for, since it's neither molecule alone
- No mention anywhere of pregnancy, breastfeeding, postpartum care, or PCOS
Pricing
| Medication | Price | Plan |
|---|---|---|
| Compounded semaglutide | $189 | Month-to-monthAll-inclusive, no dose upcharge. Longer commitment tiers are not month-to-month. |
| Compounded semaglutide | $169 | 3-month planAll-inclusive, no dose upcharge. Longer commitment tiers are not month-to-month. |
| Compounded semaglutide | $149 | 6-month planAll-inclusive, no dose upcharge. Longer commitment tiers are not month-to-month. |
| Compounded tirzepatide | $289 | Month-to-monthAll-inclusive, no dose upcharge. Longer commitment tiers are not month-to-month. |
| Compounded tirzepatide | $269 | 3-month planAll-inclusive, no dose upcharge. Longer commitment tiers are not month-to-month. |
| Compounded tirzepatide | $249 | 6-month planAll-inclusive, no dose upcharge. Longer commitment tiers are not month-to-month. |
Swipe the table to see plan details →
Many HSA and FSA plans cover GLP-1 telehealth — check yours. These figures are what PlexusDx's own site disclosed at last review; this market re-prices often, so confirm the current number at the source.
What we like
- An exclusive combined semaglutide-plus-tirzepatide 'GLP-Squared' option in a single weekly injection
- Also offers longevity/peptide programs on the same platform, for readers interested beyond GLP-1s
- Semaglutide: $189/mo monthly ($149/mo on a 6-month plan); tirzepatide: $289/mo monthly ($249/mo on a 6-month plan).
The caveats
- No mention anywhere of pregnancy, breastfeeding, postpartum care, or PCOS
- Current product pages include provider, prescription, medication and shipping; confirm any tests or exceptional services separately.
- No named compounding pharmacy or medical director found on the site
- No brand-name (FDA-approved) option
- The lower $149 and $249 figures require six-month plans; the optional $99 genetic test is additional.
The published term changes the monthly equivalent
PlexusDX lists semaglutide at $189 month to month, $169 on a three-month plan and $149 on a six-month plan. Tirzepatide is $289, $269 and $249 for the corresponding choices. The lower amounts belong to longer commitments rather than ordinary flexible monthly purchasing. A prospective patient should ask for the full payment and renewal schedule associated with the selected term before comparing one of those equivalents with another company's single-month offer.
The direct product descriptions say the price is flat across doses and includes the provider, prescription, medication and shipping, without a separate membership. That is more useful than an unexplained all-inclusive label. It still leaves practical boundaries to confirm, including any laboratory expense, supplies or exceptional service. The optional $99 genetic test is an additional purchase rather than a required membership fee. Ask what the test adds to the clinical decision before treating it as a necessary part of a standard prescription or the advertised treatment price.
GLP-Squared is a separate combination product
Plexus has also marketed GLP-Squared, combining semaglutide and tirzepatide in one weekly injection. That is a distinct preparation rather than an interchangeable way of buying either single-molecule plan. A combination name and a claim of exclusivity do not establish superiority, an approved finished product or a reason to combine prescriptions independently. The clinician should explain the exact proposed product, rationale and supporting evidence before a patient compares its price with ordinary semaglutide or tirzepatide care.
The broader platform includes longevity and peptide programs. Their presence may be convenient for someone seeking several separately assessed services, but they are not implied requirements of the weight-loss plan. Keep each proposed prescription and optional test itemized, with its own clinical purpose and charge. A larger basket or longer term should not substitute for understanding what is being prescribed. The useful starting comparison is the medication the clinician recommends, the actual term and the services included in that particular order.
Automatic renewal makes the stopping point important
Plexus's Terms describe automatic renewal and restrictions once a prescription has been transmitted to the pharmacy. A patient should therefore know the cancellation deadline and the point when an order becomes financially committed before the next shipment is expected. Stopping future renewal and recovering money already paid are different questions. Ask how those rules apply to a three- or six-month plan, especially if the clinician recommends a change after the first supply or the patient cannot continue the program.
The company advertises nationwide service but does not name a medical director or compounding pharmacy in the available information. Confirm the actual practice, dispenser and local eligibility, together with the follow-up route. Its public material does not establish a dedicated postpartum, breastfeeding or PCOS pathway, and there is no approved-brand alternative in this menu. Plexus can be assessed on its clearer current product inclusions and term ladder, but the combination offering deserves separate clinical scrutiny. Choose with the dispensing arrangement, optional-test decision and renewal limits understood, rather than the lowest six-month equivalent alone. A patient interested only in one medication can ask for a quote that excludes the optional genetic test and any unrelated longevity products.
The bottom line for mothers
Best for: Mothers who want a wider menu of dose intensities, including a microdose entry tier and a combined-molecule option, on one platform.
Alternatives to PlexusDx
These are partners — we may be paid if you sign up through these links. The full list has every provider we cover, partner or not.
- Visit CoreAge Rx86
Metabolic-Fit / 100
CoreAge RxFeatured partnerCoreAge's officially linked public offer advertises compounded semaglutide at $79/month and tirzepatide at $129/month across doses, with care and overnight shipping included. It describes one-time purchases without a required subscription. Main navigation still shows semaglutide from $99; confirm your prescription quantity and total, and read the refund limits before paying.
- Visit HealthRX57
Metabolic-Fit / 100
$165/mo semaglutide and $214/mo tirzepatide month to month, dropping to $97 and $177 on a 12-month plan — with a genuinely itemized exclusion list that explicitly screens out pregnancy, planned pregnancy, and breastfeeding rather than staying silent on it.
- Visit bmiMD45
Metabolic-Fit / 100
A complete plan table and real nationwide coverage, undercut by a homepage that strikes the same product through from two different “regular” prices.
Providers like PlexusDx
Keep comparing PlexusDx
Head-to-head & alternatives
Ranked boards
- Best GLP-1 for women
- Best GLP-1 for PCOS & insulin resistance
- Best GLP-1 for perimenopause
- Best GLP-1 while breastfeeding (safety-first)
- Cheapest GLP-1 programs
- Compounded tirzepatide providers
- Cheapest tirzepatide online
- Cheapest semaglutide online
- Where to get Zepbound online
- Semaglutide vs tirzepatide: which is right for you
PlexusDx, answered
- How much does PlexusDx cost?
- At last review, PlexusDx's lowest ongoing compounded rate was about $189/mo — $189/mo monthly ($149/mo on a 6-month plan) for semaglutide, $289/mo monthly ($249/mo on a 6-month plan) for tirzepatide. This market re-prices often, so check the current all-in figure at the source before committing.
- Is PlexusDx safe to use while breastfeeding?
- Pregnancy is the clear line: no GLP-1 is established as safe while you are pregnant. For breastfeeding, the Wegovy injection, Ozempic, Zepbound and Mounjaro labels report little or no data on the drug in breast milk and ask you and your clinician to weigh the benefits of breastfeeding against your need for the medicine. Compounded versions carry no label of their own, so that conversation matters more, not less. PlexusDx is not an exception to any of that — settle the timing with your own clinician.
- Does PlexusDx offer both semaglutide and tirzepatide?
- Yes — PlexusDx offers both molecules. Tirzepatide's dual GIP/GLP-1 action is often preferred where insulin resistance drives weight, which matters for PCOS and after gestational diabetes.
- How does PlexusDx score for mothers?
- PlexusDx scores 48/100 on our Metabolic-Fit Score, a weighted read of six things mothers actually have to care about. CoreAge Rx, a featured partner, is worth a side-by-side look.
Pricing, states and verification reflect PlexusDx's public disclosures at last review; the Metabolic-Fit Score is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.